An enolase inhibitor for the targeted treatment of ENO1-deleted cancers.

An enolase inhibitor for the targeted treatment of ENO1-deleted cancers.
复制标题

烯醇酶抑制剂,用于靶向ENO1删除的癌症。

DOI:
10.1038/s42255-020-00313-3
复制
发表时间:
2020-12
期刊:
影响因子:
20.8
通讯作者:
Muller FL
Muller FL
中科院分区:
医学1区
文献类型:
--
作者:
Lin YH;Satani N;Hammoudi N;Yan VC;Barekatain Y;Khadka S;Ackroyd JJ;Georgiou DK;Pham CD;Arthur K;Maxwell D;Peng Z;Leonard PG;Czako B;Pisaneschi F;Mandal P;Sun Y;Zielinski R;Pando SC;Wang X;Tran T;Xu Q;Wu Q;Jiang Y;Kang Z;Asara JM;Priebe W;Bornmann W;Marszalek JR;DePinho RA;Muller FL

文献摘要

参考文献

被引文献

相似文献

抑制糖酵解仍然是治疗癌症的理想方法。我们以前确定了一个子集的癌症窝藏纯合缺失的糖酵解酶烯醇化酶(ENO 1)与特殊的敏感性,抑制其冗余paralysis,ENO 2,通过一种治疗策略称为附带致死。在这里,我们表明,一种小分子烯醇化酶抑制剂,POMHEX,可以选择性地杀死ENO 1-删除神经胶质瘤细胞在低纳摩尔浓度和根除颅内原位ENO 1-删除肿瘤在小鼠在非人类灵长类动物耐受良好的剂量。我们的数据为精确肿瘤学中的附带致死能力提供了体内原理证明,并证明了POMHEX在一系列治疗环境中抑制糖酵解的潜力。
Inhibiting glycolysis remains an aspirational approach for the treatment of cancer. We previously identified a subset of cancers harboring homozygous deletion of the glycolytic enzyme Enolase (ENO1) with exceptional sensitivity to inhibition of its redundant paralogue, ENO2, through a therapeutic strategy known as collateral lethality. Here, we show that a small molecule Enolase inhibitor, POMHEX, can selectively kill ENO1-deleted glioma cells at low nanomolar concentrations and eradicate intracranial orthotopic ENO1-deleted tumors in mice at doses well-tolerated in non-human primates. Our data provide in vivo proof-of-principal for the power of collateral lethality in precision oncology and demonstrate the utility of POMHEX for glycolysis inhibition with potential across a range of therapeutic settings.
DOI: 10.1021/bi00307a038
发表时间: 1984-01-01
期刊: BIOCHEMISTRY
影响因子: 2.9
作者:
ANDERSON, VE;WEISS, PM;CLELAND, WW
通讯作者: CLELAND, WW
DOI: 10.1016/j.bmcl.2005.03.061
发表时间: 2005-06-02
影响因子: 2.7
作者:
Fonvielle, M;Mariano, S;Therisod, M
通讯作者: Therisod, M
DOI: 10.1107/s0907444909052925
发表时间: 2010-02
期刊: Acta crystallographica. Section D, Biological crystallography
影响因子: --
作者:
Adams PD;Afonine PV;Bunkóczi G;Chen VB;Davis IW;Echols N;Headd JJ;Hung LW;Kapral GJ;Grosse-Kunstleve RW;McCoy AJ;Moriarty NW;Oeffner R;Read RJ;Richardson DC;Richardson JS;Terwilliger TC;Zwart PH
通讯作者: Zwart PH
DOI: 10.1093/neuonc/nos072
发表时间: 2012-06-01
期刊: NEURO-ONCOLOGY
影响因子: 15.9
作者:
Bady, Pierre;Diserens, Annie-Claire;Hegi, Monika E.
通讯作者: Hegi, Monika E.
DOI: 10.1016/j.chembiol.2019.11.005
发表时间: 2020-02-20
影响因子: 8.6
作者:
Gaffney, Dominique O.;Jennings, Erin Q.;Galligan, James J.
通讯作者: Galligan, James J.